Search

Search results

56 results found

Adjunctive therapy with an oral H2S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fraction.

Doiron, Jake E, Huijing Xia, Xiaoman Yu, Alexandra R Nevins, Kyle B LaPenna, Thomas E Sharp, Traci T Goodchild, et al. 2024. “Adjunctive Therapy With an Oral H2S Donor Provides Additional Therapeutic Benefit Beyond SGLT2 Inhibition in Cardiometabolic Heart Failure With Preserved Ejection Fraction.”. British Journal of Pharmacology 181 (21): 4294-4310.

Hydrogen Sulfide Attenuates Renin Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney Function and Improve Exercise Tolerance in Heart Failure.

Li, Zhen, Chelsea L Organ, Jianming Kang, David J Polhemus, Rishi K Trivedi, Thomas E Sharp, Jack S Jenkins, Ya-Xiong Tao, Ming Xian, and David J Lefer. 2018. “Hydrogen Sulfide Attenuates Renin Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney Function and Improve Exercise Tolerance in Heart Failure.”. JACC. Basic to Translational Science 3 (6): 796-809.

Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction.

Sharp, Thomas E, Hajime Kubo, Remus M Berretta, Timothy Starosta, Markus Wallner, Giana J Schena, Alexander R Hobby, et al. 2017. “Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction.”. JACC. Basic to Translational Science 2 (6): 669-83.